F
REGN icon

FolioMetrix’s Regeneron Pharmaceuticals REGN Stock Holding History

FolioMetrix’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$230K Buy
+462
New +$225K 0.1% 169

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

FolioMetrix's REGN Position: Q2 2015 in Review

FolioMetrix opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2015: 462 shares worth $230K. The stake represents 0.1% of the portfolio and ranks #169 among its holdings.

541 funds tracked by Wall St. Rank hold REGN as of Q2 2015.

  • FolioMetrix held 462 shares of Regeneron Pharmaceuticals worth $230K as of Q2 2015.
  • Regeneron Pharmaceuticals was a new FolioMetrix position in Q2 2015.
  • Regeneron Pharmaceuticals made up 0.1% of FolioMetrix's portfolio in Q2 2015, its #169 holding.
  • 541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.